PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastroesophageal reflux disease |
| Phenotype | C0017168|esophageal reflux disease |
| Sentences | 33 |
| PubMedID- 23875101 | The aims of this study were to determine whether obesity is associated with gastroesophageal reflux in patients with gastroesophageal reflux disease and to identify the factors affecting increased acid exposure in obese patients. |
| PubMedID- 21602991 | Nocturnal weakly acidic reflux is as common as acid reflux in patients with gastroesophageal reflux disease, and predominates later in the night. |
| PubMedID- 25847137 | Validated questionnaires such as gastroesophageal reflux disease health-related quality of life (gerd-hrql), reflux symptom index (rsi) and achalasia disease-specific health-related quality of life were obtained pre- and postoperatively. |
| PubMedID- 25587615 | Autofluorescence imaging endoscopy for predicting acid reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 23350046 | Transient les relaxation (tlesr) with volume reflux is considered to be a major mechanism of symptomatic gastroesophageal reflux in patients with gastroesophageal reflux disease (gerd).8-10 during volume reflux, the entire surface of the distal esophagus is thought to be exposed to gastric acid. |
| PubMedID- 24676289 | Influence of exercise testing in gastroesophageal reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 22837877 | Not all reflux episodes occurring in patients with gastroesophageal reflux disease (gerd) are accompanied by reflux symptoms. |
| PubMedID- 26123332 | Methods and procedures: data on all patients undergoing poem were collected prospectively between august 2012 and june 2014 and included demographics, objective testing (48-h ph probe, manometry, endoscopy), as well as gastroesophageal reflux disease health-related quality of life (gerd-hrql), gerd symptom scale (gerss), and antacid use. |
| PubMedID- 22629750 | The article presents research data of duodenogastral reflux (dgr) role in patients with gastroesophageal reflux disease. |
| PubMedID- 21675271 | Aim: to study informative value of 24-h ph monitoring in registration of gastroesophageal and duodenogastroesophageal reflux (ger, dger) in patients with gastroesophageal reflux disease (gerd) before and after surgical treatment. |
| PubMedID- 20040914 | Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 21320138 | Randomised clinical trial: effects of monotherapy with adx10059, a mglur5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. |
| PubMedID- 24533836 | The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease. |
| PubMedID- 23128301 | Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy. |
| PubMedID- 23721547 | Background: arbaclofen placarbil is a pro-drug of the gamma-aminobutyric acid-b agonist r-baclofen that has been shown to reduce reflux episodes in patients with gastro-oesophageal reflux disease (gerd). |
| PubMedID- 20838342 | The clinical consequence is rebound acid secretion which may induce dyspeptic symptoms in healthy individuals and exacerbate reflux symptoms in patients with gastroesophageal reflux disease. |
| PubMedID- 24941823 | Objective: to investigate the association between esophageal motility and acid reflux in patients with gastroesophageal reflux disease (gerd). |
| PubMedID- 24759350 | Its principle is similar to the controlled delivery of rf energy to the lower oesophageal sphincter region (the stretta procedure), which was proposed as an alternative to standard anti-reflux surgery in patients with gastro-oesophageal reflux disease. |
| PubMedID- 24347282 | Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (gerd): a prospective, multicenter, post-marketing observational study. |
| PubMedID- 23669304 | An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 21459504 | The previous paradigm of airway reflux as synonymous with the classic gastro-oesophageal reflux disease (gord) causing heartburn has been overturned. |
| PubMedID- 22046769 | The pathological gastroesophageal reflux disease may lead to the gastroesophageal reflux disease (gerd), manifested as a spectrum of conditions including erosive esophagitis, barrett esophagus and has been linked to the development of adenocarcinoma of the esophagus. |
| PubMedID- 25965137 | Multiple new endoluminal devices and therapies have been devised to create a more effective antireflux barrier in patients with gastroesophageal reflux disease (gerd). |
| PubMedID- 24557959 | Conclusion: speed of food intake has no significant impact on acidic reflux attacks in patients with gastroesophageal reflux disease. |
| PubMedID- 24502186 | Introduction: treatment of persistence to proton pump inhibitors or non-acid reflux episodes in patients with gastroesophageal reflux disease is challenging. |
| PubMedID- 21822428 | The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 25452843 | Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease. |
| PubMedID- 22862140 | Small volume acid reflux in gastroesophageal reflux disease patients with hiatal hernia is only detectable by ph-metry but not by multichannel intraluminal impedance. |
| PubMedID- 24481258 | Most physician respondents (79.2%) reported that they would treat chronic hoarseness with reflux medication in a patient without evidence of gastroesophageal reflux disease. |
| PubMedID- 21402616 | Objective: o evaluate the efficacy and tolerability of add-on treatment with lesogaberan (azd3355), a novel reflux inhibitor, in patients with persistent gastro-oesophageal reflux disease (gord) symptoms despite proton pump inhibitor (ppi) therapy. |
| PubMedID- 25407279 | Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study. |
| PubMedID- 25392612 | The gastroesophageal reflux disease–health-related quality of life scale (gerd-hrql) was used to assess the severity of reflux.14 the gerd-hrql is a disease-specific, 10-question, 6-point likert-type scale identifying symptoms such as heartburn and bloating. |
| PubMedID- 25172606 | Gastrointestinal symptoms were evaluated with gastroesophageal reflux disease-health related quality of life (gerd-hrql) questionnaire and gastrointestinal symptom rating scale (gsrs), eating behavior with three-factor eating questionnaire before and one year after rygb. |
Page: 1